2019年冠状病毒病疫情对一组意大利系统性硬化症患者的影响。 - Suppr | 超能文献

相似文献

1

Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients.2019年冠状病毒病疫情对一组意大利系统性硬化症患者的影响。

Scand J Rheumatol. 2020 Nov;49(6):505-506. doi: 10.1080/03009742.2020.1800083. Epub 2020 Aug 28.

2

Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.当前和未来对系统性硬化症疾病修饰和低疾病活动度的展望。

Arthritis Rheumatol. 2020 Jul;72(7):1049-1058. doi: 10.1002/art.41246. Epub 2020 May 18.

3

Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group.长期环前列素治疗系统性硬化症的病情改善作用。一项回顾性分析及与对照组的比较。

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):722-7.

4

Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.慢性使用羟氯喹并未在巴西的一大群风湿疾病患者中预防 COVID-19。

Adv Rheumatol. 2021 Oct 7;61(1):60. doi: 10.1186/s42358-021-00217-0.

5

Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients.托珠单抗治疗系统性硬化症的真实世界经验：对抗拓扑异构酶阳性患者肺功能的潜在益处。

Rheumatology (Oxford). 2021 Aug 2;60(8):3945-3946. doi: 10.1093/rheumatology/keab273.

6

Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.系统性硬化症患者甲襞视频毛细血管镜检查中硬皮病模式的患病率及演变：临床和预后意义

Microvasc Res. 2015 May;99:92-5. doi: 10.1016/j.mvr.2015.03.005. Epub 2015 Apr 2.

7

Treatment of systemic sclerosis.系统性硬化症的治疗

Rheum Dis Clin North Am. 1996 Nov;22(4):893-907. doi: 10.1016/s0889-857x(05)70307-0.

8

Treatment of scleroderma.硬皮病的治疗。

Curr Opin Rheumatol. 1995 Nov;7(6):551-9. doi: 10.1097/00002281-199511000-00015.

9

Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension.系统性硬化症——系统综述：第2部分——免疫抑制、系统性硬化症相关血管病变的治疗及肺动脉高压的治疗。

Vasa. 2011 Jan;40(1):20-30. doi: 10.1024/0301-1526/a000066.

10

Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study.长期乙酰半胱氨酸治疗系统性硬皮病相关性间质性肺病：一项回顾性研究。

Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3):727-33. doi: 10.1177/039463201102400319.

引用本文的文献

1

The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis.新型冠状病毒肺炎对青少年系统性硬化症患者临床病程及治疗的影响。

Arch Rheumatol. 2022 Nov 4;38(2):267-273. doi: 10.46497/ArchRheumatol.2023.9636. eCollection 2023 Jun.

2

COVID-19 and Autoimmune Liver Diseases.新型冠状病毒肺炎与自身免疫性肝病

J Clin Med. 2022 May 10;11(10):2681. doi: 10.3390/jcm11102681.

3

COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study.2019冠状病毒病与系统性硬化症：来自意大利全国性调查研究的临床病理意义